4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-21-047612
General Counsel sold 1,200 shares at $27.00 ($32,400)
- General Counsel acquired 1,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-20 | Exercise or conversion : show line 1 in the form | +1,200 | $1.86 | $2,232 | 2,005 | D |
| 2021-07-20 | Sale : show line 2 in the form | −1,200 | $27.00 | $32,400 | 805 | D |
| Open-market sales · 1,200 sh · avg $27.00 · $32,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-07-20 | Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) | −1,200 | $1.86 | 2029-09-30 | 1,200 | 112,066 | D |
Loading xslF345X03/doc4.xml…